In this study, we report for the first time that the extract of GT (GTE) has a distinct growth-inhibitory effect on HER2-overexpressing cancer cells in vitro (Figures 1(a)–1(c)) and in vivo (Figure 5(a)). The gene discussed is ERBB2; the disease is cancer.